Tenth Annual AACR International Conference on Frontiers in Cancer Prevention Rese

第十届 AACR 癌症预防研究前沿国际会议

• 批准号: 8257005
• 负责人: Margaret Foti
• 金额: $ 2.5万
• 依托单位: AMERICAN ASSOCIATION FOR CANCER RESEARCH
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-19 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8257005
• 关键词: Advanced Malignant Neoplasm; Advocate; American Association of Cancer Research; Attention; Awareness; Basic Science; Behavioral; Boston; Carcinogens; Clinical; Collaborations; Colonoscopy; Data; Discipline; Disease; Early Diagnosis; Early treatment; Education; Effectiveness; Epidemiology; Exercise; Exposure to; Fostering; HBV Vaccination; Health Professional; Hepatitis B Virus; Human; Human Papillomavirus; Incidence; Individual; Information Technology; International; Intervention; Learning; Lesion; Life Style; Mainstreaming; Malignant Neoplasms; Massachusetts; Molecular; Patients; Physicians; Polypectomy; Population; Premalignant; Prevention; Prevention Research; Prevention strategy; Primary Prevention; Process; Public Health; Recurrence; Research; Research Personnel; Research Technics; Risk; Scientific Advances and Accomplishments; Scientist; Screening procedure; Second Primary Cancers; Secondary Prevention; Series; Specific qualifier value; Survivors; Technology; Tobacco; Tobacco use; Translating; cancer prevention; carcinogenesis; career; clinical application; exhibitions; frontier; interdisciplinary collaboration; interest; meetings; mortality; new technology; prevent; programs; skills; symposium; tertiary prevention; vaccine development

DESCRIPTION (provided by applicant): The Tenth Annual International Conference on Frontiers in Cancer Prevention Research will take place October 22-25, 2011, at the Boston Convention and Exhibition Center in Boston, Massachusetts. The AACR has long been a supporter of cancer prevention research aimed at preventing cancer through lifestyle changes and early detection and treatment. This annual AACR conference series debuted in 2002 and remains the pre-eminent cancer prevention meeting in the world. Physicians, scientists, patients, and survivor advocates learn about the latest translational discoveries from the leading basic, clinical, epidemiologic, and behavioral scientists in the field. The conference fosters interdisciplinary collaborations, accelerates progression in the field of prevention research, and promotes awareness of the vital importance of cancer prevention in reducing cancer incidence and mortality. This year's conference theme is "advancing cancer prevention through technology." The program will highlight how new technologies have advanced all disciplines of cancer prevention research, while also focusing on how these advances can be integrated across disciplines to effectively prevent cancer. Scientific advances are transforming the field of cancer prevention by providing us with the information and technology needed to understand the molecular underpinnings of carcinogenesis in humans and to identify and intervene in disease processes with unprecedented accuracy and effectiveness. By translating our understanding of the basic science into clinical application, benefits are being seen at the public health level. Several steps within carcinogenic initiation and progression are targets for cancer prevention. Primary prevention is the avoidance of exposure to carcinogens or the carcinogenic process and may be directed at the broad population of individuals who show no sign of premalignancy. Exercise and avoidance of tobacco are examples of this type of intervention. And one of the most successful primary prevention strategies is the development of vaccines such as those for HBV and HPV. Secondary prevention efforts are receiving a lot of attention and include screening and early detection, which are generally directed toward a more specified risk population. Examples of this type of prevention include colonoscopy and polypectomy. Studies have found that premalignant lesions may be more common than previously realized and it will be crucial to understand who some premalignant lesions progress to cancer and others do not. Finally, tertiary prevention is aimed at preventing recurrence or second cancers. PUBLIC HEALTH RELEVANCE: Several primary prevention strategies such as decreasing tobacco use and implementing HPV and HBV vaccination are already having a major impact on global public health by reducing cancer incidence and mortality. Important to secondary prevention strategies, several studies have found that premalignant lesions may also be more common than previously realized. Recent scientific advances are providing us with the information and technology needed to elucidate the molecular underpinnings of carcinogenesis in humans; understanding why some premalignant lesions progress to cancer while others do not will be crucial to personalizing therapy and avoiding overtreatment of patients. This annual conference provides a venue for scientists, physicians, and other health professionals to learn about and discuss the most cutting-edge research in the field and form interdisciplinary collaborations that will accelerate progression in cancer prevention research.

描述（由申请人提供）：第十届癌症预防研究边界国际会议将于2011年10月22日至25日在马萨诸塞州波士顿的波士顿大会和展览中心举行。长期以来，AACR一直是癌症预防研究的支持者，旨在通过改变生活方式的改变以及早期检测和治疗来预防癌症。该年度AACR会议系列于2002年首次亮相，仍然是世界上杰出的癌症预防会议。医师，科学家，患者和幸存者拥护者从该领域的主要基础，临床，流行病学和行为科学家那里了解了最新的翻译发现。会议促进了跨学科的合作，加快了预防研究领域的发展，并提高了人们对癌症预防在降低癌症发病率和死亡率中至关重要的认识。今年的会议主题是“通过技术预防癌症”。该计划将强调新技术如何提高预防癌症研究的所有学科，同时还要关注如何将这些进步整合到跨学科中以有效预防癌症。科学进步正在通过为我们提供了解人类癌变分子基础所需的信息和技术来改变癌症的领域，并以前所未有的准确性和有效性来识别和识别和干预疾病过程。通过将我们对基础科学的理解转化为临床应用，在公共卫生水平上正在看到益处。致癌开始和进展中的几个步骤是预防癌症的目标。一级预防是避免接触致癌物或致癌过程，并且可能针对没有表现出预先陈述迹象的个体人群。运动和避免烟草是这种干预措施的例子。最成功的主要预防策略之一是开发诸如HBV和HPV的疫苗。二级预防工作正在引起广泛关注，包括筛查和早期检测，通常针对更指定的风险人群。这种预防的例子包括结肠镜检查和多型切除术。研究发现，前病变可能比以前意识到的更为普遍，并且了解谁在癌症中进行的某些前病变发展至关重要。最后，第三级预防旨在防止复发或第二次癌症。 公共卫生相关性：几种主要的预防策略，例如减少烟草使用以及实施HPV和HBV疫苗接种，已经通过降低癌症的发病率和死亡率对全球公共卫生产生了重大影响。对于二级预防策略而言，重要的一些研究发现，预先病变的病变可能比以前意识到的更为普遍。最近的科学进步为我们提供了阐明人类癌变分子基础所需的信息和技术。理解为什么某些预调子病变会发展为癌症，而另一些人则对个性化治疗和避免患者过度治疗至关重要。这次年度会议为科学家，医师和其他卫生专业人员提供了一个场所，旨在了解并讨论该领域最尖端的研究，并进行跨学科的合作，以加速预防癌症的研究。